text: <unk>  is a leukotriene synthesis inhibitor that is FDA approved for the treatment of asthma in adults and children 12 years of age and older.   Common adverse reactions include sinusitis, nausea, and pharyngolaryngeal pain.
option_0: Zileuton
option_1: Eliglustat
option_2: Pleconaril
option_3: Plerixafor
option_4: Tasimelteon
option_5: Ecallantide
option_6: Dolastetron 
option_7: Miglustat